Insights

Strategic Acquisition Context Librede was acquired by Lygos in January 2020, signaling a consolidation in biosynthetic cannabinoid production and potential continuation of Librede’s platform capabilities within a larger commercial entity.

Small Team, High Potential With 2-10 employees and a focus on platform technologies for therapeutics, Librede represents a lean operation likely seeking partnerships, licensing, or contract development/manufacturing to scale capabilities.

Niche Platform Fit The company claims a world-first biosynthetic production platform targeting the endocannabinoid system, suggesting opportunities for collaboration with biotech, pharma, and contract manufacturing organizations seeking ECS-related therapeutics.

Funding Gap & Revenue Current revenue is under one million and total funding is modest at 1.6 million, indicating a potential need for co-development funding, strategic alliances, or investment to advance pipeline programs.

Digital & Commerce Footprint A varied tech stack including Squarespace, BigCommerce, and payment integrations implies a modern online presence; this may reflect readiness for digital marketing partnerships, e-commerce enablement, or technology services to optimize visibility and reach.

Similar companies to Librede, Inc.

Librede, Inc. Tech Stack

Librede, Inc. uses 8 technology products and services including Squarespace, Afternic, BigCommerce, and more. Explore Librede, Inc.'s tech stack below.

  • Content Management System
  • Afternic
    E-commerce
  • E-commerce Platforms
  • jQuery UI
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Braintree
    Payment Processing
  • Payment Processing
  • PHP
    Programming Languages

Librede, Inc.'s Email Address Formats

Librede, Inc. uses at least 1 email format:
Librede, Inc. Email FormatsExamplePercentage
Last@librede.comDoe@librede.com
100%

Frequently Asked Questions

What is Librede, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Librede, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Librede, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Librede, Inc.'s official website is librede.com and has social profiles on LinkedIn.

How much revenue does Librede, Inc. generate?

Minus sign iconPlus sign icon
As of July 2026, Librede, Inc.'s annual revenue is estimated to be <$1M.

What is Librede, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Librede, Inc.'s SIC code is 8733 - Noncommercial Research Organizations and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Librede, Inc. have currently?

Minus sign iconPlus sign icon
As of July 2026, Librede, Inc. has approximately 2 employees across 1 continents, including North America. Key team members include : J. S. Explore Librede, Inc.'s employee directory with LeadIQ.

What industry does Librede, Inc. belong to?

Minus sign iconPlus sign icon
Librede, Inc. operates in the Biotechnology industry.

What technology does Librede, Inc. use?

Minus sign iconPlus sign icon
Librede, Inc.'s tech stack includes Squarespace, Afternic, BigCommerce, jQuery UI, Modernizr, Braintree, PayPal and PHP.

What is Librede, Inc.'s email format?

Minus sign iconPlus sign icon
Librede, Inc.'s email format typically follows the pattern of Last@librede.com. Find more Librede, Inc. email formats with LeadIQ.

How much funding has Librede, Inc. raised to date?

Minus sign iconPlus sign icon
As of July 2026, Librede, Inc. has raised $1.6M in funding. The last funding round occurred on Feb 13, 2018 for $1.5M.

When was Librede, Inc. founded?

Minus sign iconPlus sign icon
Librede, Inc. was founded in 2009.
Librede, Inc. logo

Librede, Inc.

BiotechnologyCalifornia, United States2-10 Employees

Librede, Inc. is a biotechnology research company based in San Diego, California. It develops platform technologies intended to enable the discovery and production of new therapeutics, using biological processes to build devices and manufacture molecules. The firm has created a biosynthetic production platform that targets the endocannabinoid system, reflecting a focus on sustainable approaches to healthcare innovation. Librede operates within the biotechnology research sector, serving researchers and developers pursuing therapeutics by offering platform capabilities that support discovery and manufacturing. In January 2020, Librede was acquired by Lygos, linking its technology to Lygos’ cannabinoid production platform.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2009
Employees
2-10

Section iconFunding & Financials

  • $1.6M

    Librede, Inc. has raised a total of $1.6M of funding over 2 rounds. Their latest funding round was raised on Feb 13, 2018 in the amount of $1.5M as a Grant.

  • <$1M

    Librede, Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.